Leadership transition in Arthur J. Gallagher’s finance function
Arthur J. Gallagher (AJG) informed investors that longtime Controller and Chief Accounting Officer Richard C. Cary stepped down from these roles in late 2026, and that Kyle G. Koreyva took over as the company’s principal accounting officer.
Arthur J. Gallagher’s share price has eased recently, with a 1-day share price return of a 2.02% decline and a 7-day share price return of a 3.62% decline. It still shows a 30-day share price return of 5.10% and a 90-day share price return of 27.40%, while the 1-year total shareholder return is down 12.44%. Longer term total shareholder returns over 3 and 5 years remain positive.
Compare Arthur J. Gallagher’s leadership shift and recent share price moves with other insurance brokers by scanning our curated list of 74 resilient stocks with low risk scores.
Arthur J. Gallagher combines a long established brokerage and risk management business with recent leadership change and a mixed share price record. The key issue now is whether investors are paying a fair price for that mix.
Most Popular Narrative: 9.7% Undervalued
Arthur J. Gallagher’s last close of $262.15 sits below the most followed narrative’s fair value estimate of $290.44, which is based on detailed revenue and earnings forecasts.
Broader adoption of digital tools, enhanced data analytics, and early-stage AI projects within the company’s operations are producing measurable efficiency improvements and margin expansion, positioning net margins and overall profitability for continued long-term growth.
Read the complete narrative.Read the complete narrative.
Want to see what is behind that higher fair value for Arthur J. Gallagher? The narrative focuses on recurring revenue, richer margins, and a sizeable uplift in future earnings on a premium earnings multiple. Curious how those moving parts fit together into one valuation story?
Result: Fair Value of $290.44 (UNDERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, Arthur J. Gallagher’s story can shift quickly if property pricing continues to soften or if its heavy use of acquisitions runs into integration or regulatory hurdles.
Find out about the key risks to this Arthur J. Gallagher narrative.
Another View: Arthur J. Gallagher Looks Expensive On P/E
The most followed Arthur J. Gallagher narrative points to a 9.7% undervaluation, yet the current P/E of 42.9x tells a very different story. That multiple is roughly double the peer average of 20.1x and well above the US Insurance industry at 11.3x, compared with a fair ratio of 17.5x.
This gap suggests investors are already paying a steep premium for AJG relative to both peers and where the fair ratio indicates the market could move. The question for you is whether the quality of the business and future growth assumptions justify staying on that higher rung of the ladder.
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
If this mix of risks and rewards around Arthur J. Gallagher feels finely balanced, then now is a good time to review the detail yourself and decide where you stand based on the 2 key rewards and 3 important warning signs.
Looking for more Arthur J. Gallagher investment ideas?
If Arthur J. Gallagher has sharpened your interest, you can use this moment to broaden your watchlist and uncover fresh opportunities before other investors focus on them.
- Target dependable cash generators by scanning companies with resilient fundamentals using the list of solid balance sheet and fundamentals (52 results).
- Hunt for potential mispriced opportunities and see which companies currently appear attractively valued with the 45 high quality undervalued stocks.
- Prioritise stability and income by reviewing companies that feature in our 12 dividend fortresses.
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.
New:Manage All Your Stock Portfolios in One Place
We’ve created the ultimate portfolio companion for stock investors, and it’s free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks
Have feedback on this article? Concerned about the content? Get in touch with us directly.Alternatively, email editorial-team@simplywallst.com
MI
mitchell_lawler
The Foxhole
The world’s in stitches over robots sprinting into walls. I still think they’re the answer to our productivity problem.
What you have missed is that this event happened last year too. Last year the number was 21 seconds. This year it beat Bolt. That’s 60% improvement in an year. Now extrapolate this in many axes of work that Robots can come and fill in. The physical productivity and AI boom is just starting.
I can’t pick a company. But I can pick a person. With no doubt that’s Musk. Optimus for blue collar productivity increase and xAI for white collar productivity increase. Did anyone dabble with GrokBot here?
Great earnings season, but are the earnings real?
At first glance, this was the strongest earnings season in years. But when you look at where the growth actually came from, the story splits into two very different pictures.
85
Aug 28, 2026
About NYSE:AJG
Arthur J. Gallagher
Provides insurance and reinsurance brokerage, consulting, and third-party property/casualty claims settlement and administration services to entities and individuals worldwide.
Adequate balance sheet average dividend payer.
Similar Companies
Market Insights
Great earnings season, but are the earnings real?AN
Andrew Legget
Which payment stocks actually get paid?MI
Mitchell Lawler
Picking portfolio winners takes more than hot airAN
Andrew Legget
Advertisement
Weekly Picks
Lou_Baseneseon Oncolytics Biotech·13 days ago
The Team Behind a $2 Billion Johnson & Johnson (JNJ) Deal Just Took Over This $105 Million Cancer Biotech
Fair Value:US$3.576.1% undervalued
44followersusers have followed this narrative
·0commentsusers have commented on this narrative
·12likesusers have liked this narrative
TR
tripledubon Meta Platforms·28 days ago
The $135 Billion Bet That Should Make Every Shareholder Nervous
Taloson Voyager Technologies·22 days ago
The “Landlord of Orbit” – A Deep Value Play Ahead of the Starlab Era
Ivoedon Uber Technologies·16 days ago
Uber’s Valuation Depends On Who Captures The Economics Of Driverless Rides
RecentlyUpdated Narratives
LunaRodason Science Applications International·about 8 hours ago
SAIC | Science Applications International: What They Said vs. What They Did
Fair Value:US$119.247.5% overvalued
1followerusers have followed this narrative
·0commentsusers have commented on this narrative
·0likesusers have liked this narrative
AN
Anthony_Leeon Lotus Technology·about 11 hours ago
Tech and Tradition: Lotus Technology’s Compound Formula in Luxury EVs
Epstein_Researchon Dryden Gold·about 12 hours ago
Dryden Gold continues to expand & de-risk its flagship Gold Rock project!
Popular Narratives
oscargarciaon NVIDIA·3 months ago
The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.
CubanEroson Microsoft·about 2 months ago
A wonderful business at reasonable price.
John_Ericon MercadoLibre·26 days ago
